A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.
Clinical trial NCT07203898 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07203898
- Sponsor
- Beijing Immupeutics Medicine Technology Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2026-12-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.